Robshaw & Julian Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Robshaw & Julian Associates's PFE Position: Q2 2017 in Review
Robshaw & Julian Associates reduced its Pfizer (PFE) stake by 2.2% in Q2 2017, selling an estimated $76.5K and leaving 108,802 shares worth $3.47M. The position accounts for 2.49% of the portfolio, ranked #21.
Robshaw & Julian Associates first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $5.11M in Q1 2015. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.
- Robshaw & Julian Associates held 108,802 shares of Pfizer worth $3.47M as of Q2 2017.
- Robshaw & Julian Associates sold 2,425 Pfizer shares in Q2 2017, an estimated $76.5K.
- Pfizer made up 2.49% of Robshaw & Julian Associates's portfolio in Q2 2017, its #21 holding.
- Robshaw & Julian Associates first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
- Robshaw & Julian Associates's Pfizer position peaked at $5.11M in Q1 2015.
- 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.
Based on Robshaw & Julian Associates's 13F filing for Q2 2017, filed 3 Aug 2017.